Lupin Share Price
CMP as on 17-Sep-21 15:59
₹ 950.95Open
₹ 968.00Turnover (lac)
₹ 23,647Prev. Close
₹ 968.10Day's Vol (shares)
₹ 24,86,651CMP as on17-Sep-21 15:30
₹ 950.15Open
₹ 966.25Turnover (lac)
₹ 4,087Prev. Close
₹ 967.70Day's Vol (shares)
₹ 93,619CMP as on 17-Sep-21 0:00
₹ 948.00Open
₹ 968.00Open Interest(Contracts)
₹ 1,02,38,250VWAP
₹ 952.64Day's Vol (shares)
₹ 48,86,650News
-
Lupin launches authorized generic version of Duexis in the US
10:52 IST, Sep 16Ibuprofen and Famotidine Tablets (RLD: Duexis) had estimated annual sales of USD 765 million in the U.S. (IQVIA MAT July 2021).
-
Lupin board nods to settle litigations in Glumetza matter
9:04 IST, Sep 16Lupin assured that this settlement will not have a significant impact on the financial position of the Company.
-
Lupin launches rheumatoid arthritis treatment drug in US
15:04 IST, Sep 15Lupin on Wednesday announced the launch of rheumatoid arthritis treatment drug in the US market.
-
Nifty Pharma stocks steady amid bullish markets; Dr Reddy's, Auro Pharma outperf
13:00 IST, Sep 14Lupin dragged 0.4% at Rs980.15 per piece while Torrent Pharma was also 0.13% lower.
-
Nifty Pharma under pressure on broad-based selloff; Aurobindo Pharma, Dr Reddy's
10:50 IST, Sep 13Indias Cumulative COVID-19 vaccination coverage surpasses 73.82cr.
-
Lupin rises after partnership for new therapy for highly drug-resistant TB
11:55 IST, Sep 06Lupin added 0.75% to Rs 976.75 after the company secured a non-exclusive license from TB Alliance to manufacture the anti-TB drug preto
-
Lupin join hands with TB Alliance for a new therapy of highly drug-resistant TB;
11:52 IST, Sep 06Lupin intends to commercialize antituberculosis (TB) medicine in approximately 140 countries and territories.
-
Lupin Ltd soars 0.35%, rises for fifth straight session
13:00 IST, Sep 02Lupin Ltd is quoting at Rs 965.65, up 0.35% on the day as on 12:49 IST on the NSE. The stock is up 0.41% in last one year as compared t
-
Nifty Pharma defies bull run, sheds near 100 pts with all stocks in red; Dr Red
10:35 IST, Aug 25India reported around 37,593 new cases in the last 24 hours.
-
Lupin-led arm launches Luforbec for asthma and COPD treatment in UK
16:05 IST, Aug 24Lupin is approved to manufacture Luforbec at its sites in Pithampur in India and Coral Springs in the US.
QuickLinks for Lupin Ltd.
